Cargando…
Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy
We previously analysed clinical and immunological parameters under Trichuris suis ova (TSO) therapy in four patients with secondary progressive multiple sclerosis. The serum Brain-derived neurotrophic factor (BDNF) levels of these four patients were assessed before, during and after therapy with TSO...
Autores principales: | Rosche, Berit, Werner, Jonas, Benzel, Friderike Joëlle, Harms, Lutz, Danker-Hopfe, Heidi, Hellweg, Rainer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
EDP Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866952/ https://www.ncbi.nlm.nih.gov/pubmed/24351232 http://dx.doi.org/10.1051/parasite/2013056 |
Ejemplares similares
-
The Worm-Specific Immune Response in Multiple Sclerosis Patients Receiving Controlled Trichuris suis Ova Immunotherapy
por: Yordanova, Ivet A., et al.
Publicado: (2021) -
Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial
por: Rosche, Berit, et al.
Publicado: (2013) -
Trichuris suis ova therapy in inflammatory bowel disease: A meta-analysis
por: Huang, Xing, et al.
Publicado: (2018) -
Influence of NOD2 Variants on Trichuris suis ova Treatment Outcome in Crohn’s Disease
por: Jaeger, Simon U., et al.
Publicado: (2018) -
A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn’s Disease
por: Schölmerich, Jürgen, et al.
Publicado: (2017)